Jurgen Kuball

67PUBLICATIONS
323CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Sep 30, 2026
Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapy.

|Sep 24, 2026
Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article.

|Aug 25, 2026
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders.

|Jun 06, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

|Mar 04, 2026
Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT.

Nicole Santoro, Jarl Eduard Mooyaart, Urban Novak

|Feb 24, 2026
Commentary on "Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer".

Dorine A de Bont, Trudy Straetemans, Zsolt Sebestyén

Pageof 12

Frequent Collaborators

15 joint publications

Annalisa Ruggeri

10 joint publications

Florent Malard

9 joint publications

Christian Chabannon

9 joint publications

Ibrahim Yakoub-Agha